Technological Center “NovaMedica Innotech” started its activities in April 2017 in Moscow. It is a 100% subsidiary of the pharmaceutical company NovaMedica (investment project of RUSNANO). The center was created to develop new drugs and pilot production of solid dosage forms in accordance with the GMP standards.
NovaMedica Innotech has a unique set of innovative technological platforms for the development and production of modern competitive and effective medicines. Specialists of the R&D Center of NovaMedica Innotech develop own original products and carry out a number of projects within contracts with Russian and foreign partners.
Due to the highly qualified staff, cooperation with leading global R&D centers and leaders in various segments of the pharmaceutical industry, NovaMedica Innotech is the center of competence transfer in the field of drug development in Russia in accordance with the best global practices of GLP, GMP.
October 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
The Ministry of Health approved a new indication for a non-small cell lung cancer drug
07 November 2024
Special rules for medicines and medical devices may extend to 2028
07 November 2024
Murashko discussed the progress of Russian innovative drugs
06 November 2024
The volume of production of dietary supplements increased by 27% in 2024 in Moscow
06 November 2024